Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Capital Employed (2022 - 2025)

Autolus Therapeutics' Return on Capital Employed history spans 4 years, with the latest figure at 0.49% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 17.0% year-over-year to 0.49%; the TTM value through Dec 2025 reached 0.49%, down 17.0%, while the annual FY2025 figure was 0.44%, 2.0% up from the prior year.
  • Return on Capital Employed reached 0.49% in Q4 2025 per AUTL's latest filing, down from 0.45% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.23% in Q2 2024 to a low of 0.55% in Q3 2022.
  • Average Return on Capital Employed over 4 years is 0.38%, with a median of 0.37% recorded in 2022.
  • Peak YoY movement for Return on Capital Employed: grew 20bps in 2023, then dropped -17bps in 2025.
  • A 4-year view of Return on Capital Employed shows it stood at 0.38% in 2022, then crashed by -38bps to 0.52% in 2023, then soared by 38bps to 0.32% in 2024, then crashed by -51bps to 0.49% in 2025.
  • Per Business Quant, the three most recent readings for AUTL's Return on Capital Employed are 0.49% (Q4 2025), 0.45% (Q3 2025), and 0.41% (Q2 2025).